首页 › 基金 › Birchview Capital, LP › STOK
Birchview Capital, LP 对 STOK 的持仓历史
STOKE THERAPEUTICS INC · 医疗保健
Birchview Capital, LP 在 Q3 2026 的 13F 申报中披露持有 STOK(STOKE THERAPEUTICS INC)138,000 股,市值约 US$3.6M,约占其申报组合的 2.14%,在其申报持仓中市值排名第 12 位。 Birchview Capital, LP 最近 13 个申报季度中有 13 个季度披露了 STOK 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Birchview Capital, LP 对 STOK 的持仓演变
Birchview Capital, LP 于 Q3 2023 首次披露 STOK 持仓:85,000 股(约 US$335K)。 该持仓在 Q4 2025 达到峰值 260,000 股,市值约 US$8.3M。 在 13 次申报中,Birchview Capital, LP 2 次增持、3 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 138,000 股、市值约 US$3.6M,环比减持 -40,110 股。。 持仓曾出现大幅变动:Q4 2023 增持约 147% (随后一个季度股价上涨 157%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 85.00K | $334.90K | 新进 |
| Q4 2023 | 210.00K | $1.10M | 增持 |
| Q1 2024 | 210.00K | $2.83M | 持有 |
| Q2 2024 | 210.00K | $2.84M | 持有 |
| Q3 2024 | 210.00K | $2.58M | 持有 |
| Q4 2024 | 210.00K | $2.32M | 持有 |
| Q1 2025 | 210.00K | $1.40M | 持有 |
| Q2 2025 | 210.00K | $2.38M | 持有 |
| Q3 2025 | 210.00K | $4.93M | 持有 |
| Q4 2025 | 260.00K | $8.25M | 增持 |
| Q1 2026 | 210.00K | $6.84M | 减持 |
| Q2 2026 | 178.11K | $5.83M | 减持 |
| Q3 2026 | 138.00K | $3.59M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 STOK 与 13F 数据
STOK(STOKE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 STOK,申报仓位最大的包括:RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 STOK 的基金
- RTW INVESTMENTS, LP 5.62M 股 · $184.00M · Q2 2026
- Lynx1 Capital Management LP 4.04M 股 · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M 股 · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M 股 · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M 股 · $103.83M · Q2 2026
- BVF INC/IL 2.55M 股 · $83.36M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M 股 · $59.66M · Q2 2026
- Siren, L.L.C. 2.00M 股 · $51.88M · Q3 2026
- EcoR1 Capital, LLC 735.00K 股 · $24.05M · Q2 2026
- MPM BioImpact LLC 723.31K 股 · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K 股 · $22.90M · Q2 2026
- Troluce Capital Advisors LLC 496.42K 股 · $16.24M · Q2 2026
更多关于 Birchview Capital, LP
常见问题
How long has Birchview Capital, LP held STOK?
Birchview Capital, LP has disclosed STOK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Birchview Capital, LP's current position in STOK?
As of Q3 2026, Birchview Capital, LP holds 138.00K shares of STOK (STOKE THERAPEUTICS INC), valued at $3.59M, representing 2.14% of its reported portfolio and ranking #12.
Has Birchview Capital, LP been buying or selling STOK?
In the latest 13F filing (Q3 2026), Birchview Capital, LP reduced its position in STOK. The position peaked in Q4 2025 at 260.00K shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.